Withings launches a clinical care service for Medicare patients

Withings has spent nearly two decades selling connected health devices. Now it wants to treat patients. The company announced Withings Medical on July 9, 2026, a clinical care service that moves Withings beyond monitoring and into actually delivering care.
The service launches first in the United States for Medicare-eligible patients, operating under the ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions), a new initiative from the CMS Innovation Center that went live nationally on July 5, 2026. The model is designed to pay for outcomes in chronic disease management rather than just services delivered. That is a meaningful distinction: it means Withings Medical gets paid when patients actually get better.
At launch, the service focuses on cardiovascular and metabolic health, specifically hypertension, diabetes, and obesity. A dedicated clinical team called Withings Medical Group builds individual care plans, prescribes and adjusts medications, and supports lifestyle changes, while keeping the patient's existing primary care doctor in the loop.
How does it work?
Withings Medical treats what clinicians call cardiovascular-kidney-metabolic (CKM) conditions through two main approaches:
- Guideline-directed medications, including GLP-1 drugs and other established treatments
- Sustained lifestyle change, supported by ongoing clinical contact
The key ingredient is continuous data. Withings devices, including blood pressure monitors, smart scales, and hybrid watches, collect health data at home and feed it to the clinical team. That gives clinicians visibility into what is happening between appointments, which is typically when small problems become big ones.
When the data flags a clinical signal, the care team can act on it quickly, adjusting medications or flagging concerns before they escalate. The whole setup is built to work alongside a patient's existing primary care team, not replace it.
Why does it matter?
The American Heart Association has called CKM conditions a public health emergency. These are among the most common and costly chronic diseases in the United States, and effective treatments already exist. The problem, as Withings frames it, is access and continuity.
Effective therapies like GLP-1 medications require careful monitoring to use safely. Without continuous clinical data, many patients either don't get these treatments or don't get them adjusted properly over time. Withings Medical is built around closing that gap.
Nisha Basu, MD, MPH, Clinical Advisor for Withings Medical, put it plainly: "Millions of Americans live with chronic conditions and are unable to access consistent, high-quality care." The pitch is that combining accurate devices, research-backed diagnostics, and actual clinical treatment in one package can reach patients continuously rather than in occasional bursts.
The context
Withings is not the first company to try turning health monitoring into clinical care, but its timing is deliberate. The ACCESS Model is a ten-year, phased program, which means Withings Medical is positioning itself early in a long government experiment to see whether technology-supported, outcome-aligned care can work at scale for Medicare beneficiaries.
The broader industry shift here is real. Healthcare is slowly moving away from the episodic model, where a patient sees a doctor when something goes wrong, toward something more proactive and continuous. Remote patient monitoring, wearable diagnostics, and value-based care contracts are all pushing in the same direction.
What Withings brings to this that most startups don't is a hardware base built over 17 years. Eric Carreel, Chairman and Co-founder of Withings, described the launch as the expression of a vision the company held when it was "among the very few pioneers of health monitoring." Whether that hardware heritage translates into clinical credibility at scale is the real question the next decade will answer.
To check eligibility for the ACCESS program, visit withings.com/medical.
💡Did you know?
You can take your DHArab experience to the next level with our Premium Membership.👉 Click here to learn more
🛠️Featured tool
Easy-Peasy
An all-in-one AI tool offering the ability to build no-code AI Bots, create articles & social media posts, convert text into natural speech in 40+ languages, create and edit images, generate videos, and more.
👉 Click here to learn more

